StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.71+0.10 (+0.26%)

Close on Nov 17, 2026Market cap $27.96BP/E –Yield –

Roivant Sciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Roivant Sciences's EV/EBITDA was 0.7× on Jan 31, 2025.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20250.7×−0.1
2024Dec 31, 20240.8×–

More Roivant Sciences figures

See a number that looks wrong?